Primary GBM, which develops rapidly in older people (mean age 55) without prior brain malignancies, accounts for nearly 90% of cases and is characterized by mutations in IDH1, PDGFRA abnormalities, EGFR overexpression, PTEN mutation, and chromosome loss [10–12]. The gene discussed is PDGFRA; the disease is glioblastoma.